durch < during < dutch

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 91.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000014 (2012)	Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon]	Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica
000021 (2010)	Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]	Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000033 (2010)	Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Noriho Sakamoto [Japon] ; Yuji Ishimatsu [Japon] ; Katsumi Eguchi [Japon]	A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
000050 (2011)	Masaaki Hiura [Japon] ; Shintaro Abe ; Akinari Tabaru ; Shohei Shimajiri ; Kentaro Hanami [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Masaru Harada	Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis
000092 (2009)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon] ; Hideo Harigae [Japon]	Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
000114 (2011)	Takao Nagashima [Japon] ; Akihito Maruyama [Japon] ; Yasuyuki Kamata [Japon] ; Seiji Minota [Japon]	Unchanged serum viral load and liver function during tocilizumab treatment in a patient with rheumatoid arthritis and hepatitis C virus infection
000133 (2009)	Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]	Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000148 (2013)	L. Naumann [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Antizytokintherapie
000150 (2012)	O. Psenak [Autriche] ; A. Studnicka-Benke [Autriche] ; R. Greil [Autriche]	Sicherheit der Immunsuppressiva
000161 (2013)	I. Kötter [Allemagne] ; J. C. Henes [Allemagne]	Etablierte Medikamente
000172 (2011)	Maneesh Gogia [États-Unis] ; Daniel E. Furst [États-Unis]	Rheumatoid arthritis and pregnancy: Disease activity, pregnancy outcomes, and treatment options during pregnancy and lactation
000173 (2013)	Nam Trung Nguyen [Japon, Viêt Nam] ; Taisuke Nakahama [Japon] ; Tadamitsu Kishimoto [Japon]	Aryl hydrocarbon receptor and experimental autoimmune arthritis
000189 (2013)	Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]	Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000193 (2012)	L. K. King ; A. Lee [Australie] ; A. Anandacoomarasamy [Australie]	Use of biological disease‐modifying anti‐rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B
000196 (2008)	Y. Shirota [États-Unis] ; Gg Illei [États-Unis] ; Np Nikolov [États-Unis]	Biologic treatments for systemic rheumatic diseases
000209 (2013)	D. Ernst [Allemagne] ; R. E. Schmidt [Allemagne] ; T. Witte [Allemagne]	Sekundäre Immundefizienz bei rheumatologischen Erkrankungen
000212 (2013)	Pierre Gangloff	Biothérapie et odontologie
000214 (2012)	Fatma Alibaz-Oner [Turquie] ; Sibel Zehra Aydin [Turquie] ; Haner Direskeneli [Turquie]	Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis
000238 (2012)	H. G. Nü Lein [Allemagne]	Wie früh würden wir Biologika wirklich einsetzen?
000240 (2013)	Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]	Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "during" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "during" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    during
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021